Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

A One-Year Trial of Lamivudine for Chronic Hepatitis B

1998 • 1,779 citations

LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES

1999 • 1,119 citations

A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

1990 • 855 citations

Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B

1996 • 821 citations

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

1995 • 820 citations

Management of hepatitis B: 2000—Summary of a workshop

2001 • 789 citations

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

2001 • 641 citations

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

2000 • 503 citations

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1998 • 459 citations

Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431–435]

2003 • 455 citations

Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B

1988 • 431 citations

Long-Term Remission of Chronic Hepatitis B after Alpha-Interferon Therapy

1991 • 415 citations

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1997 • 348 citations

Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors

1989 • 306 citations

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

1999 • 300 citations

Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

1997 • 282 citations

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1992 • 242 citations

Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled Trial

1997 • 224 citations

SERUM CHOLESTEROL AND CANCER IN THE NHANES I EPIDEMIOLOGIC FOLLOWUP STUDY

1987 • 223 citations

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1988 • 178 citations

Mechanisms of Action of Interferons

1989 • 135 citations

Epidemiology of viral hepatitis: an overview

1993 • 106 citations

Evolving Concepts of the Clinical and Serologic Consequences of Hepatitis B Virus Infection

1986 • 69 citations

Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro.

1986 • 32 citations

Interferon alfa for chronic active hepatitis B

1995 • 20 citations